SCHEMBL14083653

SCHEMBL14083653

CCCCc1ccc(NC(=O)c2ccc(-c3ncccc3Cl)c(F)c2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPV1 Q8NER1 12/20 0.50
▸ NPC1 O15118 3/20 0.47
▸ RAB9A P51151 3/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ NFKB1 P19838 1/20 0.47
▸ NFKB2 Q00653 1/20 0.47
▸ RELA Q04206 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ KDM4E B2RXH2 2/20 0.46
▸ KDR P35968 1/20 0.46
▸ MAPT P10636 1/20 0.44
▸ MEN1 O00255 1/20 0.43
▸ CASP3 P42574 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ SENP8 Q96LD8 1/20 0.43
▸ SENP7 Q9BQF6 1/20 0.43
▸ SENP6 Q9GZR1 1/20 0.43
▸ KCNQ3 O43525 1/20 0.43
▸ KCNQ2 O43526 1/20 0.43
▸ KCNE1 P15382 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14083746 0.88 TRPV1 (0.49) TRPV1NPC1RAB9AALDH1A1NFKB1
SCHEMBL14084111 0.87 TRPV1 (0.60) TRPV1
SCHEMBL14083106 0.87 TRPV1 (0.48) TRPV1NPC1RAB9AALDH1A1NFKB1
SCHEMBL14083706 0.85 TRPV1 (0.54) TRPV1MEN1KMT2AKCNQ3KCNQ2
SCHEMBL14083711 0.85 MAPT (0.54) TRPV1NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL14083635 0.85 TRPV1 (0.56) TRPV1MEN1KMT2AKCNQ3KCNQ2
SCHEMBL14083707 0.85 TRPV1 (0.56) TRPV1MEN1KMT2AKCNQ3KCNQ2
SCHEMBL14083719 0.84 NPC1 (0.56) TRPV1NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL14083673 0.84 LMNA (0.53) TRPV1NPC1RAB9AALDH1A1NFKB1
SCHEMBL4590986 0.84 TRPV1 (0.67) TRPV1NPC1RAB9AALDH1A1NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof TRPV1, TRPA1, TRPV2 TRPV1 1/4885NPC1 1061/4885RAB9A 1914/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback